2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 06:16, 17 November 2023
, 17 November 2023→Potential Benefits
| Line 107: | Line 107: | ||
{| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | {| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | ||
|+ | |+ | ||
Prospects of increasing NAD+ by NMN{{pmid|37619764}} | |||
! colspan="2" |Potential health benefits in mouse models | ! colspan="2" |Potential health benefits in mouse models | ||
! colspan="2" |Results of published human clinical trials | ! colspan="2" |Results of published human clinical trials | ||